Is TYRA up or down today?
TYRA is up 15.24% today, last at 28.65. This stock moved +15.24% versus the prior close.
TYRA · TYRA
TYRA (TYRA) is trading at 28.65, up 15.24% on the session. TYRA sits at the 59% mark of its 52-week range, carries a 14-day RSI of 58, and trades below its 50-day average. Over the past month it is up 6.27%.
Leading the coverage: “Tyra Biosciences Inc (TYRA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - tradingkey.com” (Google News Company, 9d ago). TYRA is -4.16% since story.
TYRA trades on a trailing P/E of 38.8 and is running 6.06% ahead of the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
TYRA is up 15.24% today, last at 28.65. This stock moved +15.24% versus the prior close.
Leading the coverage: “Tyra Biosciences Inc (TYRA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - tradingkey.com” (Google News Company, 9d ago). TYRA is -4.16% since story. Dominant story: TYRA Stock Heads For Best Day In Nearly 10 Months — Sets Date For Key Phase 2 Bladder Cancer Drug Readout - TradingView (3 sources, neutral) RSI is 58 — leaning bullish Price below 50-day average — short-term weakness Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: Mar 2026 – Sep 2026 (126 days) · Drag or scroll left for earlier dates
TYRA Stock Heads For Best Day In Nearly 10 Months — Sets Date For Key Phase 2 Bladder Cancer Drug Readout
TYRA Stock Heads For Best Day In Nearly 10 Months — Sets Date For Key Phase 2 Bladder Cancer Drug Readout - TradingView
TYRA Stock Heads For Best Day In Nearly 10 Months — Sets Date For Key Phase 2 Bladder Cancer Drug Readout - Stocktwits
Tyra Bio rises on upcoming mid-stage trial readout for bladder cancer drug - Seeking Alpha
Tyra Bio rises on upcoming mid-stage trial readout for bladder cancer drug